Robert Malasek - Mar 15, 2024 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Financial Officer
Signature
/s/ Robert Malasek
Stock symbol
AXIM
Transactions as of
Mar 15, 2024
Transactions value $
$2,862,250,000
Form type
4
Date filed
3/19/2024, 07:16 PM
Previous filing
Sep 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Convertible Note Award $2.86B +53.5K +1.56% $53,500.00* 3.48M Mar 15, 2024 Common Stock 2.68M $0.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person acquired a Convertible Note face $53,500. The Note is convertible into shares of the Issuers common stock at a price of $0.02 per share.